Indiana § 25-26-14-11 "Wholesale distribution"

Indiana Statutes

§ 25-26-14-11 — "Wholesale distribution"

Indiana § 25-26-14-11

Title 25PROFESSIONS AND OCCUPATIONS

Art. 26PHARMACISTS, PHARMACIES, DRUG STORES

Ch. 14Wholesale Legend Drug Distributors and Third Party

This text of Indiana § 25-26-14-11 ("Wholesale distribution") is published on Counsel Stack Legal Research, covering Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ind. Code § 25-26-14-11 (2026).

Text

As used in this chapter, "wholesale distribution" means to distribute legend drugs to persons other than a consumer or patient. The term does not include:

(1)a sale or transfer between a division, a subsidiary, a parent, an affiliated, or a related company under the common ownership and control of a corporate entity;

(2)the purchase or acquisition by a hospital or other health care entity that is a member of a group purchasing organization of a drug for the hospital's or health care entity's own use from the group purchasing organization or from other hospitals or health care entities that are members of the organization;

(3)the sale or transfer of a drug by a charitable organization described in Section 501(c)(3) of the Internal Revenue Code, to:

(A)a nonprofit affiliate of the organi

Free access — add to your briefcase to read the full text and ask questions with AI

As used in this chapter, "wholesale
distribution" means to distribute legend drugs to persons other than a
consumer or patient. The term does not include:
(1) a sale or transfer between a division, a subsidiary, a parent, an
affiliated, or a related company under the common ownership and
control of a corporate entity;
(2) the purchase or acquisition by a hospital or other health care
entity that is a member of a group purchasing organization of a
drug for the hospital's or health care entity's own use from the
group purchasing organization or from other hospitals or health
care entities that are members of the organization;
(3) the sale or transfer of a drug by a charitable organization
described in Section 501(c)(3) of the Internal Revenue Code, to:
(A) a nonprofit affiliate of the organization; or
(B) a nonprofit entity described in Section 501(c)(3) of the
Internal Revenue Code that is not affiliated with the
organization;
to the extent otherwise permitted by law;
(4) the sale of a drug among hospitals or other health care entities
that are under common control;
(5) the sale of a drug for emergency medical reasons, including
transfers of legend drugs by a retail pharmacy to another retail
pharmacy to alleviate a temporary shortage, if the gross dollar
value of the transfers does not exceed five percent (5%) of the
total legend drug sales revenue of either the transferor or
transferee pharmacy during any twelve (12) consecutive month
period;
(6) the sale of a drug or the dispensing of a drug pursuant to a
prescription;
(7) the distribution of drug samples by manufacturers'
representatives or distributors' representatives;
(8) the sale of blood and blood components intended for
transfusion;
(9) the sale of a drug by a retail pharmacy to a practitioner (as
defined in IC 25-26-13-2) for office use, if the gross dollar value
of the transfers does not exceed five percent (5%) of the retail
pharmacy's total legend drug sales during any twelve (12)
consecutive months;
(10) the sale of a drug by a retail pharmacy that is ending its
business and liquidating its inventory to another retail pharmacy;
(11) drug returns by a hospital, health care entity, or charitable
institution conducted under 21 CFR 203.23;
(12) the sale of minimal quantities of drugs by retail pharmacies
to licensed practitioners for office use;
(13) the distribution of prescription drugs by the original
manufacturer of the finished form of the prescription drug or the
distribution of the co-licensed products by a partner of the
original manufacturer of the finished form of the prescription
drug;
(14) drug returns that meet criteria established by rules adopted
by the board;
(15) the sale of a drug for research or clinical trial purposes,
provided the seller is authorized by the federal Food and Drug
Administration to sell the drug for research or clinical trial
purposes; or
(16) the donation, acceptance, distribution, or dispensing of a
legend drug as part of the prescription drug donation repository
program under IC 25-26-26.

Legislative History

As added by P.L.182-1991, SEC.3. Amended by P.L.33-1993, SEC.47; P.L.212-2005, SEC.45; P.L.246-2019, SEC.19; P.L.264-2019, SEC.8; P.L.143-2022, SEC.72; P.L.208-2023, SEC.4.